4-[2-oxo-4-(4-pyrazol-1-yl-phenylcarbamoyl)-pyrrolidin-1-yl]-piperidine-1-carboxylic acid 3,5-dichloro-benzyl ester | 1248728-17-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 4-[2-oxo-4-(4-pyrazol-1-yl-phenylcarbamoyl)-pyrrolidin-1-yl]-piperidine-1-carboxylic acid 3,5-dichloro-benzyl ester
• 英文别名: (3,5-Dichlorophenyl)methyl 4-[2-oxo-4-[(4-pyrazol-1-ylphenyl)carbamoyl]pyrrolidin-1-yl]piperidine-1-carboxylate
• CAS: 1248728-17-7
• 化学式: C₂₇H₂₇Cl₂N₅O₄
• 分子量: 556.448
• InChiKey: WTPSMJPQTPUSOF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  38
• 可旋转键数：
  7
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  96.8
• 氢给体数：
  1
• 氢受体数：
  5

文献信息

• Piperidine and piperazine derivatives as autotaxin inhibitors
  申请人：Merck Patent GmbH

  公开号：EP2626072A1

  公开（公告）日：2013-08-14

  The present invention relates to piperidine and piperazine derivatives according to formulae (Ia), (Ib) and (II) as autotaxin inhibitors and the use of such compounds for the treatment and/or prophylaxis of physiological and/or pathophysiological conditions, which are caused, mediated and/or propagated by increased lysophosphatic acid levels and/or the activation of autotaxin, in particular of different cancers.

  本发明涉及根据式（Ia）、（Ib）和（II）作为自旋素抑制剂的哌啶和哌嗪衍生物，以及将此类化合物用于治疗和/或预防生理和/或病理生理状况，这些状况是由溶血磷脂酸水平升高和/或自旋素活化引起、介导和/或传播的，尤其是不同的癌症。
• PIPERIDINE AND PIPERAZINE DERIVATIVES AS AUTOTAXIN INHIBITORS
  申请人：Schiemann Kai

  公开号：US20120059016A1

  公开（公告）日：2012-03-08

  The present invention relates to piperidine and pyrazine derivatives according to formulae (Ia), (Ib) and (II) as autotaxin inhibitors and the use of such compounds for the treatment and/or prophylaxis of physiological and/or pathophysiological conditions, which are caused, mediated and/or propagated by increased lysophosphatic acid levels and/or the activation of autotaxin, in particular of different cancers.
• US20140343075A1
  申请人：——

  公开号：US20140343075A1

  公开（公告）日：2014-11-20
• US8822476B2
  申请人：——

  公开号：US8822476B2

  公开（公告）日：2014-09-02
• US9452997B2
  申请人：——

  公开号：US9452997B2

  公开（公告）日：2016-09-27